Financials SEP Analytical (Shanghai) Co., Ltd.
Equities
301228
CNE1000057C6
Business Support Services
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11.37 CNY | +5.08% | +11.25% | -31.42% |
Valuation
Fiscal Period: December | 2022 |
---|---|
Capitalization 1 | 1,850 |
Enterprise Value (EV) 1 | 1,540 |
P/E ratio | -103 x |
Yield | - |
Capitalization / Revenue | 5.26 x |
EV / Revenue | 4.38 x |
EV / EBITDA | -415 x |
EV / FCF | -17.5 x |
FCF Yield | -5.72% |
Price to Book | 2.03 x |
Nbr of stocks (in thousands) | 120,000 |
Reference price 2 | 15.42 |
Announcement Date | 4/26/23 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
Net sales 1 | 177.7 | 298 | 359.9 | 424.9 | 351.5 |
EBITDA 1 | 42.64 | 108.4 | 84.53 | 96.22 | -3.712 |
EBIT 1 | 30.94 | 86.87 | 52.9 | 57.71 | -43.11 |
Operating Margin | 17.41% | 29.15% | 14.7% | 13.58% | -12.27% |
Earnings before Tax (EBT) 1 | 32.57 | 88.39 | 58.45 | 55.94 | -24.72 |
Net income 1 | 23.29 | 70.33 | 47.82 | 50.43 | -18.07 |
Net margin | 13.11% | 23.6% | 13.29% | 11.87% | -5.14% |
EPS 2 | 0.3000 | 0.8500 | 0.5300 | 0.5600 | -0.1500 |
Free Cash Flow 1 | -41.46 | -87.47 | -60.64 | 46.01 | -88.03 |
FCF margin | -23.33% | -29.36% | -16.85% | 10.83% | -25.05% |
FCF Conversion (EBITDA) | - | - | - | 47.81% | - |
FCF Conversion (Net income) | - | - | - | 91.22% | - |
Dividend per Share | - | - | - | 0.2000 | - |
Announcement Date | 7/20/21 | 7/20/21 | 7/20/21 | 4/27/22 | 4/26/23 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - |
Net Cash position 1 | 0.59 | 54.6 | 16.6 | 12.9 | 311 |
Leverage (Debt/EBITDA) | - | - | - | - | - |
Free Cash Flow 1 | -41.5 | -87.5 | -60.6 | 46 | -88 |
ROE (net income / shareholders' equity) | 22.4% | 31.3% | 13.9% | 12.2% | -2.24% |
ROA (Net income/ Total Assets) | 10.3% | 14.7% | 6.07% | 5.66% | -2.82% |
Assets 1 | 226.9 | 478.1 | 788.4 | 890.3 | 640.8 |
Book Value Per Share 2 | 1.820 | 3.630 | 4.180 | 4.720 | 7.580 |
Cash Flow per Share 2 | 0.2700 | 1.070 | 0.9100 | 1.180 | 1.390 |
Capex 1 | 49.4 | 73.4 | 74.3 | 28.7 | 52.6 |
Capex / Sales | 27.8% | 24.62% | 20.66% | 6.75% | 14.98% |
Announcement Date | 7/20/21 | 7/20/21 | 7/20/21 | 4/27/22 | 4/26/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-31.42% | 188M | |
0.00% | 6.98B | |
-8.80% | 3B | |
-5.76% | 2.88B | |
-27.26% | 1.84B | |
+4.53% | 1.25B | |
-5.60% | 1.08B | |
-5.00% | 886M | |
-4.02% | 795M | |
-12.19% | 782M |
- Stock Market
- Equities
- 301228 Stock
- Financials SEP Analytical (Shanghai) Co., Ltd.